Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Maio

Showing results (1-10 of 250) with videos related to

Pageof 25
Sort By:
Oncoimmunology|April 16, 2014
Immune checkpoint blockade in malignant mesothelioma: A novel therapeutic strategy against a deadly disease?Luana Calabrò, Michele Maio
Journal of Translational Medicine|June 15, 2004
Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancerEster Fonsatti, Michele Maio
The Lancet. Respiratory Medicine|May 20, 2019
The future of mesothelioma treatment: time to shift gearMichele Maio, Luana Calabrò
The Lancet. Oncology|January 4, 2014
Biomarkers for immune checkpoint inhibitors--authors' replyLuana Calabrò, Michele Maio
Seminars in Oncology|October 31, 2002
European approach to antibody-based immunotherapy of melanomaMaresa Altomonte, Michele Maio
Seminars in Oncology|May 13, 2015
Immune checkpoint blockade in malignant mesotheliomaLuana Calabrò, Michele Maio
Seminars in Oncology|August 10, 2002
Introduction: Melanoma: American and European perspectives on diagnosis and treatmentEdward F McClay, Michele Maio
Seminars in Oncology|May 13, 2015
Immunologic checkpoints for cancer treatment: a continuing successMichele Maio, Anna Maria Di Giacomo
Seminars in Oncology|May 13, 2015
The ipilimumab lesson in melanoma: achieving long-term survivalJulie Delyon, Michele Maio, Celeste Lebbé
Journal of Thoracic Disease|March 7, 2018
New horizons from immunotherapy in malignant pleural mesotheliomaLuana Calabrò, Giulia Rossi, Michele Maio
Pageof 25

Showing results (1-10 of 250) with videos related to

Sort By:
Pageof 25
Oncoimmunology|April 16, 2014
Immune checkpoint blockade in malignant mesothelioma: A novel therapeutic strategy against a deadly disease?Luana Calabrò, Michele Maio
Journal of Translational Medicine|June 15, 2004
Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancerEster Fonsatti, Michele Maio
The Lancet. Respiratory Medicine|May 20, 2019
The future of mesothelioma treatment: time to shift gearMichele Maio, Luana Calabrò
The Lancet. Oncology|January 4, 2014
Biomarkers for immune checkpoint inhibitors--authors' replyLuana Calabrò, Michele Maio
Seminars in Oncology|October 31, 2002
European approach to antibody-based immunotherapy of melanomaMaresa Altomonte, Michele Maio
Seminars in Oncology|May 13, 2015
Immune checkpoint blockade in malignant mesotheliomaLuana Calabrò, Michele Maio
Seminars in Oncology|August 10, 2002
Introduction: Melanoma: American and European perspectives on diagnosis and treatmentEdward F McClay, Michele Maio
Seminars in Oncology|May 13, 2015
Immunologic checkpoints for cancer treatment: a continuing successMichele Maio, Anna Maria Di Giacomo
Seminars in Oncology|May 13, 2015
The ipilimumab lesson in melanoma: achieving long-term survivalJulie Delyon, Michele Maio, Celeste Lebbé
Journal of Thoracic Disease|March 7, 2018
New horizons from immunotherapy in malignant pleural mesotheliomaLuana Calabrò, Giulia Rossi, Michele Maio
Pageof 25